M-P Perriol1, I Jullian-Desayes2,3, M Joyeux-Faure4,5, S Bailly4,5, A Andrieux6, M Ellaffi7, F Jounieaux8, J-L Pépin4,5, C Lamblin8. 1. Unité Veille-Sommeil, Hôpital Jean Bernard, Valenciennes, France. 2. Pôle Thorax et Vaisseaux, Explorations fonctionnelles cardiorespiratoires, CHU Grenoble Alpes, Grenoble, France. ijulliandesayes@chu-grenoble.fr. 3. Laboratoire HP2, INSERM U1042, Université Grenoble Alpes, Grenoble, France. ijulliandesayes@chu-grenoble.fr. 4. Pôle Thorax et Vaisseaux, Explorations fonctionnelles cardiorespiratoires, CHU Grenoble Alpes, Grenoble, France. 5. Laboratoire HP2, INSERM U1042, Université Grenoble Alpes, Grenoble, France. 6. Pôle d'Exploration des Apnées du Sommeil, Nouvelle Clinique Bel air, Bordeaux, France. 7. Private practice, Albi, France. 8. Hôpital Privé de La Louvière, Lille, France.
Abstract
PURPOSE: In children, the usual indications for continuous positive airway pressure (CPAP) are residual OSA after adenotonsillectomy and/or persistent OSA due to obesity. Data concerning adherence (hours/night) following ambulatory CPAP initiation are scarce. METHODS: An observational cohort of 78 children was followed over 2 years. All exhibited sleep-disordered breathing (SDB) symptoms, were assessed by polysomnography, and prescribed CPAP. CPAP was initiated at hospital for 10 children. RESULTS: OSA children, mean age 10.4 ± 3.2 years, were mostly males (75.6%), with a mean body mass index of 21.2 ± 7.3 kg/m2, and mean apnea+hypopnea index of 12.2 ± 10.6 events/hour. Seventy-two children were still on CPAP at 3 months, 63 at 6 months, 55 at 1 year, and 34 at 2 years. CPAP was discontinued thanks to rehabilitation programs, dento-facial orthopedics, and/or weight loss. Mean CPAP adherence at 1, 3, 6, 12, and 24 months was respectively 6.1 ± 2.8, 6.2 ± 2.6, 6.2 ± 2.8, 6.3 ± 2.8, and 7.0 ± 2.7 h/night. There was a trend towards higher CPAP adherence and younger age, primary versus middle/high school attendance, higher baseline apnea+hypopnea index, and neurocognitive disorders. CONCLUSION: In our population, mean CPAP adherence defined in hours per night was high and did not decrease during the 24-month follow-up. These findings support the feasibility of ambulatory CPAP initiation in non-syndromic OSA. The high CPAP adherence is expected to be associated with improvements in neurocognition, and in metabolic and cardiovascular parameters.
PURPOSE: In children, the usual indications for continuous positive airway pressure (CPAP) are residual OSA after adenotonsillectomy and/or persistent OSA due to obesity. Data concerning adherence (hours/night) following ambulatory CPAP initiation are scarce. METHODS: An observational cohort of 78 children was followed over 2 years. All exhibited sleep-disordered breathing (SDB) symptoms, were assessed by polysomnography, and prescribed CPAP. CPAP was initiated at hospital for 10 children. RESULTS: OSA children, mean age 10.4 ± 3.2 years, were mostly males (75.6%), with a mean body mass index of 21.2 ± 7.3 kg/m2, and mean apnea+hypopnea index of 12.2 ± 10.6 events/hour. Seventy-two children were still on CPAP at 3 months, 63 at 6 months, 55 at 1 year, and 34 at 2 years. CPAP was discontinued thanks to rehabilitation programs, dento-facial orthopedics, and/or weight loss. Mean CPAP adherence at 1, 3, 6, 12, and 24 months was respectively 6.1 ± 2.8, 6.2 ± 2.6, 6.2 ± 2.8, 6.3 ± 2.8, and 7.0 ± 2.7 h/night. There was a trend towards higher CPAP adherence and younger age, primary versus middle/high school attendance, higher baseline apnea+hypopnea index, and neurocognitive disorders. CONCLUSION: In our population, mean CPAP adherence defined in hours per night was high and did not decrease during the 24-month follow-up. These findings support the feasibility of ambulatory CPAP initiation in non-syndromic OSA. The high CPAP adherence is expected to be associated with improvements in neurocognition, and in metabolic and cardiovascular parameters.
Entities:
Keywords:
Ambulatory; CPAP adherence; Children; OSA
Authors: Natalie DiFeo; Lisa J Meltzer; Suzanne E Beck; Laurie R Karamessinis; Mary Anne Cornaglia; Joel Traylor; John Samuel; Paul R Gallagher; Jerilynn Radcliffe; Heidi Beris; Mary Kate Menello; Carole L Marcus Journal: J Clin Sleep Med Date: 2012-06-15 Impact factor: 4.062
Authors: Mary K Lynch; Lindsey C Elliott; Kristin T Avis; David C Schwebel; Burel R Goodin Journal: Behav Sleep Med Date: 2017-05-30 Impact factor: 2.964
Authors: Melissa S Xanthopoulos; Ji Young Kim; Michael Blechner; Ming-Yu Chang; Mary Kate Menello; Christina Brown; Edward Matthews; Terri E Weaver; Justine Shults; Carole L Marcus Journal: Sleep Date: 2017-07-01 Impact factor: 5.849
Authors: Carole L Marcus; Jerilynn Radcliffe; Sofia Konstantinopoulou; Suzanne E Beck; Mary Anne Cornaglia; Joel Traylor; Natalie DiFeo; Laurie R Karamessinis; Paul R Gallagher; Lisa J Meltzer Journal: Am J Respir Crit Care Med Date: 2012-02-09 Impact factor: 21.405
Authors: Supriya K Jambhekar; Gulnur Com; Xinyu Tang; Kristi K Pruss; Rithea Jackson; Charles Bower; John L Carroll; Wendy Ward Journal: Respir Care Date: 2013-06-13 Impact factor: 2.258
Authors: Athanasios G Kaditis; Maria Luz Alonso Alvarez; An Boudewyns; Emmanouel I Alexopoulos; Refika Ersu; Koen Joosten; Helena Larramona; Silvia Miano; Indra Narang; Ha Trang; Marina Tsaoussoglou; Nele Vandenbussche; Maria Pia Villa; Dick Van Waardenburg; Silke Weber; Stijn Verhulst Journal: Eur Respir J Date: 2015-11-05 Impact factor: 16.671
Authors: Sherri L Katz; Valerie G Kirk; Joanna E MacLean; Glenda N Bendiak; Mary-Ann Harrison; Nicholas Barrowman; Lynda Hoey; Linda Horwood; Stasia Hadjiyannakis; Laurent Legault; Bethany J Foster; Evelyn Constantin Journal: J Clin Sleep Med Date: 2020-02-07 Impact factor: 4.062
Authors: Louella Amos; Olufunke Afolabi-Brown; Dominic Gault; Robin Lloyd; Moshe Y Prero; Carol L Rosen; Raman K Malhotra; Jennifer L Martin; Kannan Ramar; James A Rowley; Fariha Abbasi-Feinberg; R Nisha Aurora; Vishesh K Kapur; Uzma Kazmi; David Kuhlmann; Eric J Olson; Anita V Shelgikar; Sherene M Thomas; Lynn Marie Trotti Journal: J Clin Sleep Med Date: 2022-08-01 Impact factor: 4.324
Authors: Miriam R Weiss; Michelle L Allen; Jeremy S Landeo-Gutierrez; Jenny P Lew; Julia K Aziz; Sylvan S Mintz; Claire M Lawlor; Benjamin J Becerra; Diego A Preciado; Gustavo Nino Journal: J Clin Sleep Med Date: 2021-05-01 Impact factor: 4.062